Mölnlycke Health Care publishes Annual report for 2024

Healthcare systems around the globe face multiple challenges and reducing greenhouse gases (GHG) emissions is one of them. Today, healthcare's climate footprint corresponds to roughly 4 percent of the global net GHG  emissions. Within MedTech, purchased products and services account for a large part of the total carbon dioxide emissions. Circular design  plays a key role in improving resource efficiency, contributing to achieving environmental goals.   “Designing for circularity is about creating products and solutions that maximise the value of resources, while minimising waste. This means that the products are designed to be reused, repaired, recycled and recirculated in a way that supports a circular economy where resources are kept in use for as long as possible,” says Caterina Camerani, VP Sustainability at Mölnlycke. From cradle to grave (to cradle) Mölnlycke is active in the transition towards a circular economy and sustainability is a strategic priority for us. We lead the way when it comes to manufacturing products in renewable materials in certain product categories. Some of our solutions are certified according to the International Sustainability and Carbon Certification System (ISCC) (see here for the exact list of solutions). Caterina stresses the importance of the sustainability aspects being present in all parts of the value chain, with a holistic cradle-to-grave perspective. “Rather than being a stand-alone pillar, sustainability should be integrated at all levels. We contribute to reducing GHG emissions not only by improving our existing products, but also by, for example, replacing fossil materials with renewable alternatives during the manufacturing process and looking at all stages in the product's life cycle,” she says. As of December 2024, Mölnlycke secured 100 percent renewable electricity for all existing factories and the headquarters in Gothenburg, Sweden (see here  for details). We will continue to source renewable electricity through 2030, as pledged in one of the near-term targets validated by Science Based Targets initiative. “We are also downgauging our product packaging to reduce waste and optimise resource use. When we establish a new factory, we carry out careful analyses to identify environmental and social hotspots, which allows us to minimise our impact on both the environment and people from the start,” says Caterina. Waste management important for a closed loop Waste management is crucial to creating a closed loop. Even when packaging is designed with lower weight and use renewable materials, it is not certain that they will be handled correctly after use. Mölnlycke’s view is that this requires healthcare professionals to have the right knowledge. It also requires initiating collaborations with waste management partners. There is a lot to be gained from this type of cross-sector partnerships. A frictionless flow generates higher value for patients and healthcare professionals. This means, among other things, that the focus in the OR can be on patients and clinical outcomes instead of administrative or logistical  tasks. Post-operative waste management is one of these tasks. Mölnlycke strives to identify the non-value adding tasks in the OR and to contribute to optimising the flow so that more time is spent on tasks that matter for clinical outcomes   (access our Non-Value Report 2025 here). To help customers monitor GHG emissions and track sustainability targets, Mölnlycke has developed a CO2 calculator tool that calculates the environmental impact of our products, making it easier for healthcare providers to take informed decisions. In the tool customers can compare how much GHG emissions are reduced by using solutions containing renewable raw materials in comparison to solutions in Mölnlycke’s assortment that has not yet incorporated renewable materials. Digital product passport “All information in the calculator is based on facts,” emphasises Caterina Camerani, also mentioning the growing need to offer healthcare providers holistic transparent product information, for example through digital product passports. “Through such product passports customers could easily scan a QR code to obtain all the necessary information about, for example, recycling potential and environmental impact of a given product. Mölnlycke strives to drive innovation that creates sustainable solutions in healthcare. And the vision is clear – we want to revolutionise healthcare for people and planet.” To access the original article by Mathias Pernheim in Swedish click here.  

Mölnlycke has been awarded the platinum medal in Ecovadis Sustainability Rating, which places us in the top 1 percent of all companies assessed. EcoVadis is a globally trusted provider of business sustainability ratings with a network of more than 130,000 rated companies. Their rating recognises Mölnlycke’s strengths in environmental impact management, labour & human rights interactions, ethical governance and sustainable supply chain partnerships. Mölnlycke have been utilising feedback from EcoVadis, business partners and customers to drive continual improvement in sustainability each year. The acknowledgement of Mölnlycke’s achievments in these areas motivates us to be bolder and go further, driving positive change both for people and planet.

How to stay safe and avoid burns Make sure your grill is in a safe location. The grill should be placed well away from the home, deck railings and out from under eaves and overhanging branches. Only grill outside. Keep children and pets away. Keep children and pets at least one meter away from the grill area. Keep your grill clean. Keep your grill clean by removing grease or fat buildup from the grills and in trays below the grill. Let it cool completely. When you are finished grilling, let the coals cool completely before disposing of them in a metal container.

Mölnlycke intends to issue a new 10-year EUR bond under its Euro Medium Term Note (EMTN) programme. The bond will be listed on the Euro MTF market of the Luxembourg Stock Exchange. At the same time Mölnlycke invites its holders of the outstanding EUR 500m bond due February 2025 note to tender any and all of their notes for purchase by the company.

The benchmarking procedure Mölnlycke are in the second year of working with EcoVadis as an independent and credible organisation to benchmark strengths and improvement opportunities. The rating process required extensive amounts of data and documentation, and therefore teamwork between global sustainability, legal and compliance, information technology, procurement excellence, and people experience teams. Our submission was assessed over a four week period. As a continuation from the previous assessment, results and feedback will be used to prioritise improvement plans. The result A gold medal is awarded to the all top 5%, and our score puts us into the top 3% of all organisations from all industries worldwide. Particularly recognized during the submission were Mölnlycke's commitment to Science Based Targets and measurable improvements in emissions, ​the strength of Mölnlycke procedures relating to human rights, ​demonstrable progress in gender equality, ​and the availability of the Ethics Hotline to all Mölnlycke's stakeholders The results certificate is available to download for verification below, EcoVadis will also provide a detailed validated scorecard to users of their platform.

Since 1977, Phoenix Society has served burn survivors, their loved ones, burn care professionals, researchers and others committed to empowering the burn community to enable transformational healing. With the overarching vision of uniting the voice of the burn community globally to “advance lifelong healing, optimal recovery, and burn prevention”, the Phoenix Society offers programmes, tools, education and events to bring this vision to life. With our wide range of burn care solutions including for example cleansing, gentle wound dressings and scar management, Mölnlycke is uniquely positioned to support Phoenix Society initiatives. Our advanced wound care dressings are enabled by Safetac® technology, a gentle silicone adhesive that reduces pain and minimises skin trauma of burn survivors at dressing change. Mölnlycke also provide information about burn dressings and healing through educational content, clinical evidence, and tips and tricks on how to apply burn care. Inline quote: Anders Andersson   The power of partnership The partnership between Phoenix Society and Mölnlycke brings together two organisations driven by a mission to make survivors’ healing easier and their lives fuller by reaching survivors earlier, minimising the impact of burns and giving survivors the solutions, resources and community needed to facilitate recovery and support.

Performance highlights Mölnlycke reported strong growth in 2023, with net sales reaching EUR 1,924 million, an 8% increase in constant currency rates. The EBITDA grew by 14% to EUR 545 million, reflecting substantial organic growth and market share gains across most markets. Sustainability achievements We made significant strides in operationalising our sustainability roadmap 2030. Mölnlycke’s near-term greenhouse gas emission reduction targets were validated by the Science Based Targets initiative. Noteworthy progress was made in our journey towards 100% fossil-free electricity by the end of 2024, with 61% fossil-free electricity share in 2023. We also achieved a 20% reduction in overall absolute greenhouse gas emissions across the entire value chain compared to the 2021 baseline. Finally, we expanded the scope of Life Cycle Assessment to cover 30% of our portfolio in terms of net sales. Zlatko annual report news quote   Innovation and quality highlights To enhance surgical performance, Mölnlycke introduced hand scanning technology using artificial intelligence and machine learning for optimal glove fit, launched Mepilex® Up in the US, upgraded the Mepilex® Border Post-Op product family globally and registered Hibiwash®, - the new colour- and fragrance-free Hibi formula. We also successfully completed the transition to Medical Device Regulation (MDR), one of the first MedTech companies to do so. Strategic investments Mölnlycke secured long-term financing through a EUR 400 million Eurobond and a EUR 350 million Revolving Credit Facility. We also decided to invest EUR 60 million to increase production capacity, including a new Mepilex Border Flex production line and a new Ethylene Oxide sterilisation unit in Finland.